SMITHKLINE BEECHAMP P L C has a total of 16 patent applications. Its first patent ever was published in 1994. It filed its patents most often in United Kingdom, Brazil and China. Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are ZERIA PHARM CO LTD, TOA EIYO LTD and KOYA KEIZO.
# | Country | Total Patents | |
---|---|---|---|
#1 | United Kingdom | 9 | |
#2 | Brazil | 2 | |
#3 | China | 2 | |
#4 | Australia | 1 | |
#5 | African Intellectual Property Organization | 1 | |
#6 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Heterocyclic compounds | |
#2 | Medical preparations | |
#3 | Therapeutic chemical compounds | |
#4 | Acyclic or carbocyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Buckingham Robin Edwin | 1 |
#2 | Brown Adrian | 1 |
#3 | Best D J | 1 |
#4 | Cawthorne Michael Anthony | 1 |
#5 | Liu Yong-Ling | 1 |
#6 | Wyman Paul Adrian | 1 |
#7 | Ho Tim Chien Ting | 1 |
#8 | Raby Ronald K Jr | 1 |
#9 | Mcallister Stephen Mark Brown | 1 |
#10 | Emilsson Valur | 1 |
Publication | Filing date | Title |
---|---|---|
US2001044458A1 | Use of insulin sensitisers for treating renal diseases | |
AU7526798A | Acetamide and urea derivatives, process for their preparation and their use in the treatment of cns disorders | |
BR9714726A | Use of leptin antagonists in the treatment of diabetes | |
GB9418792D0 | Novel device | |
GB9418677D0 | Process | |
GB9418693D0 | Novel process | |
GB9418676D0 | Process | |
GB9418680D0 | Process | |
GB9418678D0 | Process | |
GB9418674D0 | Process | |
GB9418671D0 | Process | |
GB9418679D0 | Process |